Graphene Oxide Nanoscale Platform Enhances the Anti-Cancer Properties of Bortezomib in Glioblastoma Models (2022)

First Author: Sharp P

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/adhm.202201968

PubMed Identifier: 36300643

Publication URI: http://europepmc.org/abstract/MED/36300643

Type: Journal Article/Review

Parent Publication: Advanced Healthcare Materials

Issue: 3

ISSN: 2192-2640